Status:
UNKNOWN
An Enhanced Artificial Intelligence Breast MRI Interpretation System
Lead Sponsor:
Jamil Kanfoud
Collaborating Sponsors:
Brunel University London
First Option Software Ltd.
Conditions:
Breast Cancer
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
Interpretation of breast MR images is a very time-consuming process and places a great burden on breast radiologists. This project aims to develop a technical solution that addresses this healthcare c...
Detailed Description
Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015. In the UK, one in five cases of breast cancer results in a fatality. The Intell...
Eligibility Criteria
Inclusion
- Breast MRI scans
- MRI examinations undertaken at partner NHS Trust in the UK
- MRI examinations undertaken on the MRI system currently installed at partner NHS Trust site (since 2008)
Exclusion
- Incomplete breast MRI datasets
- Breast MRI without lesions
- Breast lesion on MRI not biopsied
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
1526 Patients enrolled
Trial Details
Trial ID
NCT03829423
Start Date
April 1 2019
End Date
July 1 2020
Last Update
February 6 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.